Bill Cassidy actually said...
The questions are, the guidance on the statistical approaches to analytical similarity is particularly important as it impacts initial improvability as a biosimilar under the 351K.
Context
Cassidy emphasizes the importance of guidance on statistical approaches for biosimilars.
09/16/2015